Elon Musk’s aerospace company, SpaceX, is reportedly targeting an initial public offering (IPO) with an ambitious valuation exceeding two trillion US dollars. This comes amidst a dynamic global business landscape, highlighted by several other key developments.
The pharmaceutical sector is voicing increasing concerns over the future of its European manufacturing sites, apprehensive about the potential impact of new US tariffs. Concurrently, the chemical industry is experiencing a significant downturn in sentiment, raising fears of impending job cuts across the sector.
In contrast, the broader industrial sector is identifying growing opportunities within the armaments industry, pointing to a shift in market focus. On a more positive note for the healthcare industry, Eli Lilly has successfully secured US approval for its highly anticipated weight-loss pill.
